Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Breckenridge Pharmaceutical has announced that the FDA has granted final approval for the company's abbreviated new drug application to market its estradiol or norethindrone acetate 1mg/0.5mg tablets.
Subscribe to our email newsletter
Estradiol or norethindrone acetate tablets are AB rated to Activella, a brand product marketed by Novo Nordisk, which is used as a treatment for moderate to severe vasomotor symptoms associated with menopause, and as prevention for postmenopausal osteoporosis.
Breckenridge is actively seeking development and marketing alliances with domestic and foreign companies for generic and branded pharmaceuticals.